Neurocta - Company finances
|
EUR
|
2020
From: 2020-04-17
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 0 | 2,860 | 45,478 | 42,253 | 60,474 | 129,083 |
| Profit before tax | 0 | -10,797 | 15,876 | 6,714 | 6,786 | 20,228 |
| Net profit | 0 | -10,797 | 15,876 | 6,520 | 6,592 | 18,970 |
| Equity | 500 | -10,297 | 5,579 | 2,855 | 10,696 | 50,416 |
| Liabilities | 0 | 66 | 1,405 | 36,201 | 74,588 | 20,634 |
| Non-current assets | 0 | 2,609 | 1,601 | 30,245 | 25,986 | 38,987 |
| Current assets | 500 | 3,773 | 5,383 | 8,811 | 59,298 | 32,063 |
| Total assets | 500 | 6,382 | 6,984 | 39,056 | 85,284 | 71,050 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 848 | 3,543 | 2,355 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | +1490.1% | -7.1% | +43.1% | +113.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | -169.2% | 227.3% | 16.7% | 7.7% | 26.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | - | 284.6% | 228.4% | 61.6% | 37.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -377.5% | 34.9% | 15.4% | 10.9% | 14.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -377.5% | 34.9% | 15.9% | 11.2% | 15.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.3 | 12.7 | 7.0 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | 42,253 | 36,284 | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Neurocta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-23 | 2026-07-26 | 0.52 |
| 2026-06-11 | 2026-06-24 | 14.26 |
| 2026-05-17 | 2026-06-08 | 14.26 |
| 2026-05-03 | 2026-05-14 | 0.88 |
| 2026-04-27 | 2026-04-29 | 0.88 |
| 2026-04-26 | 2026-04-26 | 113.60 |
| 2026-04-24 | 2026-04-25 | 114.48 |
| 2026-04-20 | 2026-04-23 | 118.60 |
| 2026-03-17 | 2026-03-27 | 193.74 |
| 2026-02-18 | 2026-02-25 | 140.81 |
| 2025-06-08 | 2025-06-09 | 0.24 |
| 2025-05-04 | 2025-06-04 | 0.24 |
| 2025-04-24 | 2025-04-29 | 0.24 |
| 2025-01-22 | 2025-01-22 | 115.99 |
| 2025-01-16 | 2025-01-21 | 111.73 |
| 2024-12-22 | 2024-12-29 | 318.83 |
| 2024-12-17 | 2024-12-20 | 318.83 |
| 2024-11-18 | 2024-11-24 | 1054.77 |
| 2024-10-16 | 2024-10-21 | 242.87 |
| 2024-04-23 | 2024-05-14 | 0.05 |
Neurocta - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Neurocta is: 6 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-02 | 2026-09-02 | 5.71 |
| 2026-07-03 | 2026-08-01 | 5.1 |
| 2026-06-24 | 2026-07-02 | 1262.16 |
| 2026-06-03 | 2026-06-23 | 1.38 |
| 2026-06-01 | 2026-06-02 | 114.99 |
| 2026-05-20 | 2026-05-31 | 114.63 |
| 2026-05-13 | 2026-05-19 | 113.61 |
| 2026-05-01 | 2026-05-12 | 2.1 |
| 2026-04-30 | 2026-04-30 | 0.75 |
| 2026-04-26 | 2026-04-27 | 174.48 |
| 2026-04-16 | 2026-04-25 | 182.17 |
| 2026-03-17 | 2026-03-17 | 101.33 |
| 2026-03-16 | 2026-03-16 | 101.8 |
| 2026-03-12 | 2026-03-15 | 101.18 |
| 2026-03-02 | 2026-03-11 | 0.16 |
| 2026-02-12 | 2026-03-01 | 0.05 |
| 2026-02-03 | 2026-02-11 | 28.25 |
| 2026-01-29 | 2026-02-02 | 28.2 |
| 2026-01-01 | 2026-01-28 | 4.2 |
| 2025-12-03 | 2025-12-31 | 0.2 |
| 2025-12-01 | 2025-12-02 | 371.5 |
| 2025-11-28 | 2025-11-30 | 371.1 |
| 2025-06-28 | 2025-06-30 | 1.76 |
| 2025-06-19 | 2025-06-27 | 0.76 |
| 2025-06-04 | 2025-06-14 | 0.72 |
| 2025-06-02 | 2025-06-03 | 60.86 |
| 2025-05-31 | 2025-06-01 | 60.24 |
| 2025-05-24 | 2025-05-30 | 60.14 |
| 2025-04-28 | 2025-05-23 | 0.14 |
| 2025-03-28 | 2025-04-26 | 0.01 |
| 2025-01-15 | 2025-01-15 | 405.26 |
| 2024-12-22 | 2025-01-01 | 9.45 |
| 2024-12-21 | 2024-12-21 | 4.05 |
| 2024-12-14 | 2024-12-20 | 992.18 |
| 2024-11-18 | 2024-12-13 | 0.18 |
| 2024-11-17 | 2024-11-17 | 336.41 |
| 2024-10-15 | 2024-10-16 | 368.19 |
| 2024-09-26 | 2024-10-14 | 0.62 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Neurocta, MB (code 305539321) is a Small partnership engaged in research and development in technical sciences. In the latest financial year 2025, the company generated revenue of €129.1K and net profit of €19.0K, corresponding to a profit margin of 14.7%. Performance improved sharply over the last three years: revenue rose from €42.3K in 2023 to €60.5K in 2024 and then to €129.1K in 2025, while net profit increased from €6.5K to €6.6K and then €19.0K. The balance sheet showed total assets of €71.0K in 2025, supported by equity of €50.4K and liabilities of €20.6K. Compared with 2024, equity strengthened and liabilities declined, while assets moved from €39.1K in 2023 to €85.3K in 2024 and then €71.0K in 2025. Key ratios for 2025 indicate solid efficiency and capital structure, with ROE of 37.6%, ROA of 26.7%, debt-to-equity of 0.41 and asset turnover of 1.82x. Revenue per employee was €129.1K and profit per employee was €19.0K.